VPT — VentriPoint Diagnostics Balance Sheet
0.000.00%
- CA$23.64m
- CA$24.93m
- CA$0.05m
Annual balance sheet for VentriPoint Diagnostics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.014 | 0.526 | 9.27 | 5.19 | 1.29 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.068 | 0.165 | 0.197 | 0.374 | 0.285 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.176 | 0.715 | 9.5 | 5.66 | 1.64 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.138 | 0.087 | 0.043 | 0.313 | 0.247 |
Net Intangible Assets | |||||
Total Assets | 0.314 | 0.802 | 9.54 | 5.98 | 1.88 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.92 | 1.82 | 1.09 | 1.06 | 1.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 2.78 | 3.15 | 1.21 | 1.42 | 1.69 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -2.47 | -2.35 | 8.33 | 4.55 | 0.19 |
Total Liabilities & Shareholders' Equity | 0.314 | 0.802 | 9.54 | 5.98 | 1.88 |
Total Common Shares Outstanding |